Renata Świerzbińska Selected Research

Tick-Borne Encephalitis (Encephalitis, Tick Borne)

1/2021	The increased intrathecal expression of the monocyte-attracting chemokines CCL7 and CXCL12 in tick-borne encephalitis.
2/2020	Assessment of Coxiella burnetii presence after tick bite in north-eastern Poland.
1/2020	Analysis of CCL-4, CCL-17, CCL-20 and IL-8 concentrations in the serum of patients with tick-borne encephalitis and anaplasmosis.
3/2019	Assessment of the tau protein concentration in patients with tick-borne encephalitis.
12/2018	Evaluation of NSE and S100B in patients with tick-borne encephalitis.
4/2018	The intrathecal expression and pathogenetic role of Th17 cytokines and CXCR2-binding chemokines in tick-borne encephalitis.
1/2018	Intrathecal expression of IL-5 and humoral response in patients with tick-borne encephalitis.
1/2017	The increased concentration of macrophage migration inhibitory factor in serum and cerebrospinal fluid of patients with tick-borne encephalitis.
2/2016	The expression of the chemokine receptor CCR5 in tick-borne encephalitis.
2/2015	Increased concentration of interferon lambda-3, interferon beta and interleukin-10 in the cerebrospinal fluid of patients with tick-borne encephalitis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Renata Świerzbińska Research Topics

Disease

11	Tick-Borne Encephalitis (Encephalitis, Tick Borne) 01/2021 - 11/2012
5	Meningitis 01/2021 - 02/2015
5	Lyme Disease (Disease, Lyme) 02/2020 - 02/2015
4	Leukocytosis (Pleocytosis) 01/2021 - 11/2012
3	Erythema 01/2021 - 02/2015
3	Encephalitis (Encephalitis, Rasmussen) 03/2019 - 02/2016
3	Infections 01/2018 - 06/2016
2	Aseptic Meningitis 01/2021 - 04/2018
2	Coinfection 02/2020 - 01/2020
2	Meningoencephalitis 03/2019 - 02/2015
2	Inflammation (Inflammations) 04/2018 - 01/2018
1	Paresis (Hemiparesis) 03/2021
1	Paralysis (Palsy) 03/2021
1	Facial Paralysis (Facial Palsy) 03/2021
1	Tick Bites 02/2020
1	Q Fever (Fever, Q) 02/2020
1	Anaplasmosis 01/2020
1	West Nile Fever 02/2016
1	Herpes Zoster 01/2016
1	Superinfection 01/2016
1	Acrodermatitis (Gianotti Crosti Syndrome) 03/2015

Drug/Important Bio-Agent (IBA)

5	AntibodiesIBA 03/2021 - 02/2015
5	ChemokinesIBA 01/2021 - 02/2016
4	CytokinesIBA 01/2021 - 01/2016
3	Immunoglobulin G (IgG)IBA 02/2020 - 01/2016
3	Interleukin-17 (Interleukin 17)IBA 04/2018 - 01/2016
2	Immunoglobulin M (IgM)IBA 03/2021 - 01/2018
2	Carnitine (L-Carnitine)FDA LinkGeneric 03/2017 - 03/2016
2	Interleukin-10 (Interleukin 10)IBA 06/2016 - 02/2015
2	Interleukin-23 (Interleukin 23)IBA 01/2016 - 11/2012
2	interleukin-21 (interleukin 21)IBA 01/2016 - 11/2012
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Interleukin-8 (Interleukin 8)IBA 01/2020
1	tau Proteins (tau Protein)IBA 03/2019
1	Phosphopyruvate Hydratase (Enolase)IBA 12/2018
1	Interleukin-5 (Interleukin 5)IBA 01/2018
1	Macrophage Migration-Inhibitory FactorsIBA 01/2017
1	Interleukin-22 (IL-22)IBA 06/2016
1	1-dodecylpyridoxal (PLD)IBA 03/2016
1	LigandsIBA 02/2016
1	Chemokine ReceptorsIBA 02/2016
1	Interleukin-4 (Interleukin 4)IBA 01/2016
1	Interleukin-12 (IL 12)IBA 01/2016
1	fas Receptor (CD95 Antigen)IBA 03/2015
1	InterferonsIBA 02/2015
1	Interferon-betaIBA 02/2015
1	DNA (Deoxyribonucleic Acid)IBA 02/2015
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 11/2012

Therapy/Procedure

2	Aftercare (After-Treatment) 01/2021 - 01/2020